Article

Be prepared: EMRs are here to stay

Now is the time for practitioners to begin to do their homework on electronic medical records (EMRs) systems. The federal government has a significant mandate with a large budget to standardize and implement their use in clinical practice, said Richard A. Lewis, MD, at Glaucoma Day at the American Society of Cataract and Refractive Surgery meeting.

Now is the time for practitioners to begin to do their homework on electronic medical records (EMRs) systems. The federal government has a significant mandate with a large budget to standardize and implement their use in clinical practice, said Richard A. Lewis, MD, at Glaucoma Day at the American Society of Cataract and Refractive Surgery meeting.

"This will be your most expensive practice investment bar none. Therefore, before you make your purchase, evaluate all the vendors, view the systems, and discuss their performance with existing users," said Dr. Lewis, a glaucoma specialist in private practice, Sacramento, CA.

Having used a DOS-based EMR system for the last 18 years, Dr. Lewis told attendees that he has found it advantageous for reducing costs, enhancing revenue, improving administration efficiency, and enhancing clinical efficiency care and service. However, because DOS was abandoned, the system lost its industry support, and since it does not readily allow for integration of diagnostic tests, he is currently researching alternatives.

In investigating options, practitioners should be sure they fully understand the company, the product and the long-term service agreement, as each of those elements is extremely important to how the system will be managed. In addition, it is important to select an EMR team within the office that will be involved in implementation and to anticipate a 6- to 12-month period of disruption before the system will be operating smoothly.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.